Question 1

What is Boston Collaborative Drug Surveillance Program known for?

Accepted Answer

In research, Boston Collaborative Drug Surveillance Program stands highest in Medicine (#3,294 of 14,558 worldwide) and Health Sciences (#3,839 of 16,688 worldwide), over all time.

Question 2

How does Boston Collaborative Drug Surveillance Program rank in research?

Accepted Answer

Boston Collaborative Drug Surveillance Program ranks #19,629 of 34,923 institutions worldwide on research quality over all time, and #4,071 of 7,310 in the United States.

Question 3

Who are the top researchers at Boston Collaborative Drug Surveillance Program?

Accepted Answer

Ranked on the quality score, Hershel Jick, Susan Sara Jick and Jane Porter lead among researchers whose main affiliation is Boston Collaborative Drug Surveillance Program.

Question 4

What are the most cited papers from Boston Collaborative Drug Surveillance Program?

Accepted Answer

The most cited paper from Boston Collaborative Drug Surveillance Program is "Statins and the risk of dementia" (Hershel Jick, GL Zornberg, Susan Sara Jick et al., 2000), with 1,770 citations. Next come "Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs" (978) and "Validation of information recorded on general practitioner based computerised data resource in the United Kingdom." (843).

Question 5

Which research topics does Boston Collaborative Drug Surveillance Program publish most on?

Accepted Answer

By volume in 2022-now: Global Cancer Incidence and Screening, Venous Thromboembolism Diagnosis and Management, Pharmacovigilance and Adverse Drug Reactions and Medication Adherence and Compliance.

Question 6

Which keywords describe research at Boston Collaborative Drug Surveillance Program?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Epidemiology, Treatment, Clinical Trials, Breast Cancer, Diagnosis, Cardiovascular Risk and Cardiovascular Disease.

Question 7

Which fields of science does Boston Collaborative Drug Surveillance Program work in?

Accepted Answer

In all years, 74% of research at Boston Collaborative Drug Surveillance Program is in Health Sciences, 17% in Life Sciences. Its largest fields are Medicine (71%), Biochemistry, Genetics and Molecular Biology (8%), Pharmacology, Toxicology and Pharmaceutics (5%). It does 3.1× the world's share of Health Sciences.

Question 8

Is Boston Collaborative Drug Surveillance Program's research output growing?

Accepted Answer

Output in 2022-2025 was 18% lower than in 2018-2021.

Discussion